Both aging and cancer are marked by dysregulation of key nutrient-sensing pathways, particularly those involving insulin and IGF-1 signaling, mTOR (mechanistic target of rapamycin), and AMPK (AMP-activated protein kinase) [88]. The gene discussed is MTOR; the disease is cancer.